Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Bioverativ Inc (BIVV)

57.75 -0.19 (-0.33%)

4/27/2017  2:33pm

Open:

57.87

Pre. Close:

57.94

High:

57.96

Low:

57.31

Volume:

213,088

Market Cap:

6.24B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-04-27 2:25:01 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 68.62     One year: 80.15

Support:

Support1: 52.92    Support2: 49.32

Resistance:

Resistance1: 58.75    Resistance2: 68.62

Pivot:

56.92

Moving Averages:

MA(5): 57.75     MA(20): 56.15

MA(100):     MA(250):

MACD:

MACD(12,26): 1.60     Signal(12,26,9): 1.63

%K %D:

%K(14,3): 82.37     %D(3): 84.56

RSI:

RSI(14): 64.04

52-Week:

High: 58.75  Low: 40.00  Change(%): 28.2

Average Vol(K):

3-Month: -10000000000  10-Days 883

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BIVV has closed below upper band by 25.8%. Bollinger Bands are 0% narrower than normal.

Headline News

Mon, 24 Apr 2017 13:18:45 GMT
Gabelli Downgrades Bioverativ Inc (BIVV) to Hold

Thu, 13 Apr 2017 17:37:30 GMT
Bioverativ: Just Stop The Bleeding

Wed, 26 Apr 2017 02:26:15 GMT
Q1 2017 EPS Estimates for Bioverativ Inc (BIVV) Raised by Leerink Swann

Wed, 26 Apr 2017 14:00:21 GMT
How Technical Charts Are Flashing For Bioverativ Inc. (BIVV), Superior Energy ...

Thu, 13 Apr 2017 20:26:15 GMT
BRIEF-Healthcor Management reports a 5.1 pct passive stake in Bioverativ Inc

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA

Industry:  NA

Shares Out. (M)

107.98

Shares Float (M)

99.58

% Held by Insiders

% Held by Institutions

Shares Short (K)

4500

Shares Short Prior Month (K)

4080

Stock Financials

EPS

4.070

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

5.240

PEG Ratio

2.32

Profit Margin

49.54

Operating Margin

37.58

Return on Assets (ttm)

34.5

Return on Equity (ttm)

92.5

Qtrly Rev. Growth

47.1

Gross Profit (p.s.)

Sales Per Share

8.218

EBITDA (p.s.)

3.252

Qtrly Earnings Growth

215.70

Operating Cash Flow (M)

301.60

Levered Free Cash Flow (M)

122.94

FoxReading.com

Valuation

P/E

14.17

P/E Growth Ratio

P/BV

11.01

P/S

7.02

P/CF

20.65

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.